• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD Back to Search Results
Model Number 4473
Medical Device Problem Codes Difficult to Remove (1528); Defective Device (2588); Material Integrity Problem (2978)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 08/21/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this right atrial (ra) lead was attempted to be removed due to the extraction of the older non-boston scientific right ventricular (rv) lead.The ra lead was broken during extraction attempted and it was surgically abandoned.The non-bsc rv lead was abandoned as well.The physician then successfully implanted two new leads while using the current pacemaker.No additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this right atrial (ra) lead was attempted to be removed due to the extraction of the older non-boston scientific right ventricular (rv) lead.The ra lead was broken during extraction attempted and it was surgically abandoned.The non-bsc rv lead was abandoned as well.The physician then successfully implanted two new leads while using the current pacemaker.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of difficult to remove was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined implant instructions were adequate.The manual was unlikely to be the cause of the reported complaint.The device was not returned for analysis; therefore, a technical analysis could not be performed.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FINELINE II EZ STEROX
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
#12, rd. #698
dorado PR 00646
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key23019942
Report Number2124215-2025-63734
Device Sequence Number9741255
Product Code DTB
UDI-Device Identifier00802526265020
UDI-Public(01)00802526265020(17)040602
Combination Product (Y/N)Y
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P960004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2002
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date06/02/2004
Device Model Number4473
Device Catalogue Number4473
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/21/2025
Supplement Date Received by Manufacturer04/15/2026
Initial Report FDA Received Date09/10/2025
Supplement Report FDA Received Date04/16/2026
Date Device Manufactured06/02/2002
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age48 YR
Patient SexMale
-
-